Reframing recalcitrance for small-cell lung cancer
- PMID: 33957222
- DOI: 10.1016/j.annonc.2021.04.022
Reframing recalcitrance for small-cell lung cancer
Conflict of interest statement
Disclosure FHB reports honoraria and research support from Roche, BMS, MSD, Astra-Zeneca and Abbvie.
Comment on
-
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.Ann Oncol. 2021 Jul;32(7):839-853. doi: 10.1016/j.annonc.2021.03.207. Epub 2021 Apr 20. Ann Oncol. 2021. PMID: 33864941 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
